Abstract
Lymphoma is a malignant tumor, and diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Due to its biological characteristics, surgical treatment is difficult. The main treatment for DLBCL is chemotherapy, with the R-CHOP regimen being the most common. The vast majority of patients require lifelong treatment. Myelosuppression during chemotherapy is the most common adverse reaction in DLBCL patients and directly affects the progress of chemotherapy. Accurately predicting whether patients need early intervention before chemotherapy can greatly improve their prognosis. In this paper, we propose a neural network that uses PET/CT images of subcutaneous adipose tissue before treatment to predict myelosuppression in DLBCL patients. The model achieves a classification accuracy of 93.57%. This indicates that the growth distribution pattern and metabolic characteristics of adipose tissue are important for DLBCL patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sehn, L.H., Salles, G.: Diffuse large b-cell lymphoma. N. Engl. J. Med. 384(9), 842–858 (2021)
de Leval, L., Jaffe, E.S.: Lymphoma Classification. Cancer J. (Sudbury, Mass.) 26(3), 176–185 (2020)
Matasar, M.J., Zelenetz, A.D.: Overview of lymphoma diagnosis and management. Radiol. Clin. North Am. 46(2), 175–98 vii (2008)
Barrington, S.F., Trotman, J.: The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma. Lancet. Haematol. 8(1), e80–e93 (2021)
Boccia, R., Glaspy, J., Crawford, J., Aapro, M.: Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed? Oncologist 27(8), 625–636 (2022)
Voog, E., et al.: Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: role of the tumor necrosis factor ligand-receptor system. J. Clin. Oncol. Offic. J. Am. Soc. Clin. Oncol. 18(2), 325–331 (2000)
Esteva, A., et al.: A guide to deep learning in healthcare. Nat. Med. 25(1), 24–29 (2019)
Matsushima, K., et al.: A high-volume trauma intensive care unit can be successfully staffed by advanced practitioners at night. J. Crit. Care 33, 4–7 (2016)
Hu, X., et al.: Coarse-to-fine adversarial networks and zone-based uncertainty analysis for NK/T-cell lymphoma segmentation in CT/PET images. IEEE J. Biomed. Health Inform. 24(9), 2599–2608 (2020)
Higgins, M.I., Marquardt, J.P., Master, V.A., Fintelmann, F.J., Psutka, S.P.: Machine learning in body composition analysis. Eur. Urol. Focus 7(4), 713–716 (2021)
Acknowledgements
This work is supported by “National Natural Science Foundation of China” (No. 82220108007). We thank B.A. Qi Qiu from Foreign Studies College of Northeastern University, China, for her professional English proofreading in this paper.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Du, T., Sun, H., Yang, J., Grzegorzek, M., Li, C. (2024). Deep Learning-Based Prediction of Myelosuppression in Lymphoma Patients During Chemotherapy Using Multimodal Radiological Images with Subcutaneous Adipose Tissue. In: You, P., Liu, S., Wang, J. (eds) Proceedings of International Conference on Image, Vision and Intelligent Systems 2023 (ICIVIS 2023). ICIVIS 2023. Lecture Notes in Electrical Engineering, vol 1163. Springer, Singapore. https://doi.org/10.1007/978-981-97-0855-0_3
Download citation
DOI: https://doi.org/10.1007/978-981-97-0855-0_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-97-0854-3
Online ISBN: 978-981-97-0855-0
eBook Packages: EngineeringEngineering (R0)